Hyloris Pharmaceuticals SA (EBR: HYL)
Belgium flag Belgium · Delayed Price · Currency is EUR
5.82
-0.08 (-1.36%)
Sep 4, 2024, 2:30 PM CET

Hyloris Pharmaceuticals Revenue

In the year 2023, Hyloris Pharmaceuticals had annual revenue of 532.00K EUR, down -75.23%. Hyloris Pharmaceuticals had revenue of -396.00K in the half year ending December 31, 2023, a decrease of -148.71%.

Revenue
532.00K
Revenue Growth
-75.23%
P/S Ratio
39.87
Revenue / Employee
102.78K
Employees
41
Market Cap
168.00M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023532.00K-1.62M-75.23%
Dec 31, 20222.15M749.00K53.54%
Dec 31, 20211.40M599.00K74.88%
Dec 31, 2020800.00K246.00K44.40%
Dec 31, 2019554.00K80.00K16.88%
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition